Ductal carcinoma is the most common type of breast cancer and begins in the milk ducts of the breast. There are two main forms: ductal carcinoma in situ (DCIS), which is a non-invasive stage confined to the milk ducts, and invasive ductal carcinoma (IDC), which has spread beyond the ducts into surrounding breast tissue.

What Is Ductal Carcinoma?

Ductal carcinoma develops in the cells lining the milk ducts that carry milk from the lobules to the nipple.

The two primary types include:

DCIS is considered non-invasive but is usually treated because doctors cannot predict which cases may later become invasive. IDC requires treatment based on its stage and biological characteristics.

 

How Ductal Carcinoma Is Diagnosed Before Treatment

A complete diagnosis helps determine the most appropriate treatment approach.

Common diagnostic tests include:

• Mammogram

• Breast ultrasound

• Breast MRI in selected situations

• Needle biopsy

• Pathology examination

• Hormone receptor testing

• HER2 testing for invasive breast cancer

• Imaging tests if cancer spread is suspected

The pathology report provides information about tumor grade, hormone receptor status, HER2 status, and other features that help guide treatment decisions.

 

Factors That Influence Treatment

Treatment is individualized because every breast cancer is different.

Healthcare teams typically consider:

• Stage of cancer

• Tumor size

• Tumor grade

• Hormone receptor status

• HER2 status

• Lymph node involvement

• Age

• Menopausal status

• Overall health

• Genetic testing results when appropriate

These factors help determine whether surgery alone is sufficient or whether additional treatments are recommended.

 

Surgery for Ductal Carcinoma

Surgery is often the first treatment for both DCIS and many early-stage invasive ductal carcinomas. The goal is to remove the cancer while preserving as much healthy tissue as medically appropriate.

 

Lumpectomy (Breast-Conserving Surgery)

A lumpectomy removes the tumor along with a margin of healthy tissue.

Lumpectomy is commonly used for:

• DCIS

• Early-stage invasive ductal carcinoma

• Smaller tumors confined to one area

After a lumpectomy, radiation therapy is commonly recommended to reduce the chance of cancer returning in the same breast.

 

Benefits of Lumpectomy

• Preserves most breast tissue.

• Shorter recovery than mastectomy in many cases.

• Effective for many early-stage breast cancers when combined with radiation.

Recovery After Lumpectomy

Recovery usually involves:

• Mild pain or tenderness.

• Temporary swelling.

• Limited arm movement for several days.

• Gradual return to normal activities.

Recovery varies depending on the extent of surgery and lymph node procedures.

Mastectomy

A mastectomy removes the entire breast.

This procedure may be recommended when:

• DCIS involves multiple areas.

• The tumor is large compared with breast size.

• Clear surgical margins cannot be achieved.

• There is a high genetic risk in certain situations.

• Invasive cancer requires more extensive surgery.

Several types of mastectomy exist, including simple mastectomy, skin-sparing mastectomy, and nipple-sparing mastectomy in selected cases.

 

Breast Reconstruction

Breast reconstruction may be performed at the time of mastectomy or later.

Reconstruction methods include:

• Implant reconstruction.

• Tissue flap reconstruction.

• Combination techniques.

The choice depends on medical factors and personal preferences.

Sentinel Lymph Node Biopsy

Lymph nodes help determine whether invasive cancer has spread.

A sentinel lymph node biopsy removes the first lymph nodes most likely to receive cancer cells from the breast.

This procedure is commonly performed for invasive ductal carcinoma and in selected DCIS cases when mastectomy is performed or invasive cancer is suspected.

 

Axillary Lymph Node Surgery

If cancer is found in lymph nodes, additional lymph node surgery may sometimes be necessary.

The decision depends on:

• Number of affected nodes.

• Tumor size.

• Type of surgery.

• Radiation treatment plan.

Lymph node surgery can increase the risk of arm swelling known as lymphedema.

Radiation Therapy for Ductal Carcinoma

Radiation therapy uses high-energy beams to destroy remaining cancer cells after surgery.

Radiation is commonly recommended after lumpectomy because it lowers the risk of recurrence in the treated breast.

 

When Radiation Therapy Is Used

Radiation may be recommended after:

• Lumpectomy for DCIS.

• Lumpectomy for invasive ductal carcinoma.

• Mastectomy in selected higher-risk invasive cancers.

Radiation is not required after every mastectomy.

Types of Radiation Therapy

Common radiation techniques include:

• Whole-breast radiation.

• Partial-breast radiation for selected patients.

• Boost radiation to the surgical site.

• Regional lymph node radiation in certain invasive cancers.

Possible Side Effects

Common temporary side effects include:

• Fatigue.

• Skin redness.

• Skin irritation.

• Breast swelling.

• Tenderness.

Most skin changes gradually improve after treatment ends.

Hormone Therapy for Hormone Receptor-Positive Cancer

Hormone therapy is used when cancer cells have estrogen or progesterone receptors.

Hormone therapy helps reduce the risk of recurrence by blocking hormones that can stimulate cancer growth.

 

Hormone Therapy Medicines

Common hormone therapies include:

• Tamoxifen.

• Aromatase inhibitors.

• Ovarian suppression in selected premenopausal patients.

Treatment duration commonly ranges from five to ten years depending on individual risk factors.

When Hormone Therapy Is Recommended

Hormone therapy may be recommended after:

• DCIS with hormone receptor-positive cells.

• Early-stage invasive ductal carcinoma.

• Some higher-risk invasive cancers following surgery and radiation.

Possible Side Effects

Potential side effects vary by medication and may include:

• Hot flashes.

• Joint stiffness.

• Bone loss with certain medications.

• Vaginal dryness.

• Fatigue.

Healthcare providers monitor patients throughout treatment.

Chemotherapy for Invasive Ductal Carcinoma

Chemotherapy uses medications that destroy rapidly dividing cancer cells throughout the body.

Unlike DCIS, chemotherapy is not routinely used for ductal carcinoma in situ. It is considered for invasive ductal carcinoma based on tumor biology and recurrence risk.

 

When Chemotherapy May Be Recommended

Factors include:

• Larger tumors.

• Lymph node involvement.

• Triple-negative breast cancer.

• HER2-positive breast cancer.

• High-risk genomic test results.

• Higher tumor grade.

Chemotherapy may be given before surgery (neoadjuvant therapy) or after surgery (adjuvant therapy).

Goals of Chemotherapy

• Reduce tumor size before surgery.

• Destroy remaining cancer cells after surgery.

• Lower recurrence risk.

• Treat cancer that has spread.

Common Side Effects

Side effects depend on the medications used and may include:

• Hair loss.

• Fatigue.

• Nausea.

• Mouth sores.

• Increased infection risk.

• Temporary changes in appetite.

Supportive medications often help manage these effects.

Targeted Therapy for HER2-Positive Ductal Carcinoma

HER2-positive breast cancer produces excess HER2 protein, which promotes cancer growth.

Targeted therapy blocks this protein and improves treatment outcomes for HER2-positive invasive breast cancer.

 

When Targeted Therapy Is Used

Targeted therapy is commonly combined with chemotherapy for:

• Early HER2-positive invasive cancer.

• Locally advanced disease.

• Metastatic HER2-positive breast cancer.

Benefits

Targeted therapy specifically attacks HER2-positive cancer cells while limiting damage to many normal cells.

Monitoring During Treatment

Treatment may involve periodic heart function testing because some HER2-targeted medications can affect heart function.

Immunotherapy for Triple-Negative Breast Cancer

Immunotherapy helps the immune system recognize and attack cancer cells.

It is primarily used for certain cases of triple-negative invasive ductal carcinoma, particularly advanced or high-risk disease.

 

Who May Receive Immunotherapy?

Eligibility depends on:

• Cancer stage.

• PD-L1 testing.

• Overall treatment plan.

• Tumor characteristics.

Immunotherapy is not used for most DCIS cases.

Treatment for Ductal Carcinoma In Situ (DCIS)

DCIS is Stage 0 breast cancer confined to the milk ducts.

Although DCIS has not invaded surrounding tissue, treatment is recommended because some cases may later become invasive.

 

Common DCIS Treatment Plan

Typical treatment includes:

1. Lumpectomy.

2. Radiation therapy after lumpectomy in many cases.

3. Hormone therapy if hormone receptors are positive.

4. Mastectomy for extensive or multicentric DCIS.

Chemotherapy is generally not part of DCIS treatment.

 

Active Surveillance Research

Researchers continue studying whether carefully selected low-risk DCIS patients may safely undergo active surveillance instead of immediate surgery.

These approaches remain under investigation and are not standard treatment for most patients.

 

Treatment for Early-Stage Invasive Ductal Carcinoma

Stages I through III invasive ductal carcinoma often involve multiple treatments.

Treatment may include:

• Surgery.

• Radiation therapy.

• Hormone therapy.

• Chemotherapy.

• Targeted therapy.

• Immunotherapy for selected patients.

The sequence depends on cancer stage and tumor biology.

 

Neoadjuvant Therapy

Neoadjuvant treatment occurs before surgery.

Potential benefits include:

• Shrinking tumors.

• Making breast-conserving surgery possible.

• Assessing treatment response.

• Treating microscopic disease early.

Neoadjuvant therapy may include chemotherapy, targeted therapy, hormone therapy in selected cases, or immunotherapy depending on tumor type.

Adjuvant Therapy

Adjuvant therapy occurs after surgery.

Its purpose is to reduce the risk that cancer returns locally or elsewhere in the body.

Adjuvant treatment may include:

• Radiation.

• Hormone therapy.

• Chemotherapy.

• Targeted therapy.

Treatment for Advanced or Metastatic Ductal Carcinoma

Stage IV invasive ductal carcinoma has spread beyond the breast.

Treatment focuses on controlling disease, reducing symptoms, and maintaining quality of life.

Possible treatments include:

• Hormone therapy.

• Targeted therapy.

• Chemotherapy.

• Immunotherapy.

• Radiation therapy for symptom control.

• Surgery in selected situations.

Treatment often changes over time depending on how the cancer responds.

Recovery After Ductal Carcinoma Treatment

Recovery depends on the treatments received.

After Surgery

Recovery commonly includes:

• Wound healing.

• Arm exercises.

• Activity restrictions during early healing.

• Follow-up appointments.

After Radiation

Skin changes gradually improve over several weeks.

Fatigue often improves after treatment ends.

During Hormone Therapy

Regular follow-up visits help monitor side effects and long-term health.

Possible Side Effects of Treatment

Different treatments produce different side effects.

Side effects vary widely between individuals and treatment regimens.

Follow-Up Care After Treatment

Regular follow-up remains an important part of breast cancer care.

Follow-up may include:

• Physical examinations.

• Mammograms after breast-conserving surgery.

• Imaging when medically indicated.

• Monitoring hormone therapy.

• Managing long-term treatment effects.

• Bone health evaluation for some hormone therapies.

The follow-up schedule depends on the type of ductal carcinoma and completed treatments.

 

Lifestyle During Recovery

Recovery often includes attention to overall health.

Healthcare providers may discuss:

• Balanced nutrition.

• Regular physical activity as tolerated.

• Maintaining a healthy weight.

• Limiting alcohol intake.

• Smoking cessation.

• Bone health during hormone therapy.

• Emotional and mental health support.

Lifestyle measures do not replace medical treatment but can support overall health during recovery.

Questions Commonly Asked About Ductal Carcinoma Treatment

Is ductal carcinoma always treated with surgery?

Surgery is the most common treatment for DCIS and many early-stage invasive ductal carcinomas. The type of surgery depends on tumor size, location, and other medical factors.

 

Does every person need radiation therapy?

No. Radiation is commonly recommended after lumpectomy but is not necessary after every mastectomy or every DCIS treatment plan.